293 related articles for article (PubMed ID: 21833729)
1. 18F-FDG positron emission tomography: potential utility in the assessment of Crohn's disease.
Shyn PB
Abdom Imaging; 2012 Jun; 37(3):377-86. PubMed ID: 21833729
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
[TBL] [Abstract][Full Text] [Related]
3. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease.
Shyn PB; Mortele KJ; Britz-Cunningham SH; Friedman S; Odze RD; Burakoff R; Goldberg JE; Erturk M; Silverman SG
J Nucl Med; 2010 Dec; 51(12):1841-8. PubMed ID: 21078803
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies.
Neurath MF; Vehling D; Schunk K; Holtmann M; Brockmann H; Helisch A; Orth T; Schreckenberger M; Galle PR; Bartenstein P
Am J Gastroenterol; 2002 Aug; 97(8):1978-85. PubMed ID: 12190164
[TBL] [Abstract][Full Text] [Related]
5. 18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.
Holtmann MH; Uenzen M; Helisch A; Dahmen A; Mudter J; Goetz M; Schreckenberger M; Galle PR; Bartenstein P; Neurath MF
Dig Dis Sci; 2012 Oct; 57(10):2658-68. PubMed ID: 22569824
[TBL] [Abstract][Full Text] [Related]
6. Paediatric gastric and intestinal Crohn's disease detected by (18)F-FDG PET/CT.
Wang G; Ma Y; Chen L; Ma C
Hell J Nucl Med; 2014; 17(3):208-10. PubMed ID: 25526756
[TBL] [Abstract][Full Text] [Related]
7. Role of 18F-fluorodeoxyglucose Positron Emission Tomography in the Monitoring of Inflammatory Activity in Crohn's Disease.
Russo EA; Khan S; Janisch R; Gunn RN; Rabiner EA; Taylor SA; Matthews PM; Orchard TR
Inflamm Bowel Dis; 2016 Nov; 22(11):2619-2629. PubMed ID: 27753695
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease.
Ahmadi A; Li Q; Muller K; Collins D; Valentine JF; Drane W; Polyak S
Inflamm Bowel Dis; 2010 Jun; 16(6):974-81. PubMed ID: 19885907
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography enterography and 18F-FDG PET/CT features of primary signet ring cell carcinoma of the small bowel in a patient with Crohn's disease.
Paparo F; Piccardo A; Clavarezza M; Piccazzo R; Bacigalupo L; Cevasco L; Marinaro E; Rollandi GA
Clin Imaging; 2013; 37(4):794-7. PubMed ID: 23768742
[TBL] [Abstract][Full Text] [Related]
10. [
Li Y; Beiderwellen K; Nensa F; Grüneisen J; Dobos G; Herrmann K; Lauenstein T; Umutlu L; Langhorst J
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1382-1393. PubMed ID: 29455313
[TBL] [Abstract][Full Text] [Related]
11. Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.
Domachevsky L; Leibovitzh H; Avni-Biron I; Lichtenstein L; Goldberg N; Nidam M; Groshar D; Bernstine H; Ben-Bassat O
Contrast Media Mol Imaging; 2017; 2017():7167292. PubMed ID: 29097934
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial.
Li Y; Langhorst J; Koch AK; Demircioglu A; Nensa F; Kirchner J; Beiderwellen K; Catalano O; Forsting M; Herrmann K; Umutlu L
J Nucl Med; 2019 Jun; 60(6):851-857. PubMed ID: 30389814
[TBL] [Abstract][Full Text] [Related]
13. The pivotal role of FDG-PET/CT in modern medicine.
Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
[TBL] [Abstract][Full Text] [Related]
14. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic imaging in Crohn's disease: what is the new gold standard?
Dambha F; Tanner J; Carroll N
Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):421-36. PubMed ID: 24913382
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
18. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
19. PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake.
Groshar D; Bernstine H; Stern D; Sosna J; Eligalashvili M; Gurbuz EG; Niv Y; Fraser G
J Nucl Med; 2010 Jul; 51(7):1009-14. PubMed ID: 20554741
[TBL] [Abstract][Full Text] [Related]
20. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
